Axsome Drug Patent Portfolio
Axsome owns 1 orange book drug protected by 120 US patents Given below is the list of Axsome's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11844797 | Combination of dextromethorphan and bupropion for treating depression | 20 Apr, 2043 | Active |
| US11839612 | Compounds and combinations thereof for treating neurological and psychiatric conditions | 02 Mar, 2043 | Active |
| US11752144 | Compounds and combinations thereof for treating neurological and psychiatric conditions | 23 Feb, 2043 | Active |
| US12042473 | Compounds and combinations thereof for treating neurological and psychiatric conditions | 23 Feb, 2043 | Active |
| US11986444 | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan | 15 Feb, 2043 | Active |
| US12036191 | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan | 15 Feb, 2043 | Active |
| US11730706 | Treatment of depression in certain patient populations | 23 Jan, 2043 | Active |
| US11883373 | Treatment of depression in certain patient populations | 23 Jan, 2043 | Active |
| US11717518 | Bupropion dosage forms with reduced food and alcohol dosing effects | 20 Jan, 2043 | Active |
| US11925636 | Bupropion dosage forms with reduced food and alcohol dosing effects | 20 Jan, 2043 | Active |
| US11896563 | Bupropion and dextromethorphan for reduction of suicide risk in depression patients | 01 Dec, 2041 | Active |
| US10780064 | Bupropion as a modulator of drug activity | 07 Jan, 2040 | Active |
| US10925842 | Bupropion as a modulator of drug activity | 07 Jan, 2040 | Active |
| US10940124 | Bupropion as a modulator of drug activity | 07 Jan, 2040 | Active |
| US10966942 | Bupropion as a modulator of drug activity | 07 Jan, 2040 | Active |
| US10780066 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 09 Nov, 2034 | Active |
| US10058518 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10064857 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10080727 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US10092560 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US10092561 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | 05 Nov, 2034 | Active |
| US10105327 | Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US10105361 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US10251879 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10463634 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US10512643 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US10548857 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US10596167 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | 05 Nov, 2034 | Active |
| US10772850 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10786469 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US10786496 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US10799497 | Combination of dextromethorphan and bupropion for treating depression | 05 Nov, 2034 | Active |
| US10806710 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10864209 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10874663 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10874664 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10874665 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10881624 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US10881657 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10894046 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10894047 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10898453 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10933034 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10945973 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10966941 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US10966974 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11020389 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11058648 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11090300 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11096937 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11123343 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11129826 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11141388 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11141416 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11147808 | Method of decreasing the fluctuation index of dextromethorphan | 05 Nov, 2034 | Active |
| US11185515 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11191739 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11197839 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11207281 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11213521 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11229640 | Combination of dextromethorphan and bupropion for treating depression | 05 Nov, 2034 | Active |
| US11234946 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11253491 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11253492 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11273133 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11273134 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11285118 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11285146 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11291638 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11291665 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11298351 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11298352 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11311534 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11344544 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11357744 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11364233 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11382874 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11419867 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11426370 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11426401 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11433067 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11439636 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11478468 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11497721 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11510918 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11517542 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11517543 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11524007 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11524008 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11534414 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11541021 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11541048 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11596627 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11617728 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11617747 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11779579 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US11969421 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US12109178 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US9168234 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US9198905 | Compositions and methods for reducing dextrorphan plasma levels and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9205083 | Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan | 05 Nov, 2034 | Active |
| US9238032 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | 05 Nov, 2034 | Active |
| US9278095 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US9314462 | Compositions and methods for increasing dextromethorphan plasma levels and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9370513 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9375429 | Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan | 05 Nov, 2034 | Active |
| US9408815 | Bupropion as a modulator of drug activity | 05 Nov, 2034 | Active |
| US9421176 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9457023 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9457025 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | 05 Nov, 2034 | Active |
| US9474731 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9486450 | Hydroxybupropion and related compounds as modulators of drug plasma levels | 05 Nov, 2034 | Active |
| US9700528 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9700553 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9707191 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9763932 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9861595 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9867819 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US9968568 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | 05 Nov, 2034 | Active |
| US8569328 | Compositions and methods comprising tilidine or related compounds and dextromethorphan | 29 Oct, 2033 | Active |
Latest Legal Activities on Axsome's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Axsome.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 17 Jul, 2024 | US10894047 |
|
Email Notification
Critical
| 02 Jul, 2024 | US11439636 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 02 Jul, 2024 | US11439636 |
|
Email Notification
Critical
| 02 Jul, 2024 | US11426401 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 02 Jul, 2024 | US10881657 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 02 Jul, 2024 | US11426401 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 01 Jul, 2024 | US10881624 |
|
Email Notification
Critical
| 27 Jun, 2024 | US10786469 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 27 Jun, 2024 | US10780066 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 27 Jun, 2024 | US10786469 |
|
Email Notification
Critical
| 27 Jun, 2024 | US10780066 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Jun, 2024 | US10806710 |
|
Email Notification
Critical
| 26 Jun, 2024 | US9238032 |
|
Email Notification
Critical
| 26 Jun, 2024 | US10806710 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 26 Jun, 2024 | US9238032 |
Axsome Drug Patents' Oppositions Filed in EPO
Axsome drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on May 31, 2021, by Elkington And Fife Llp. This opposition was filed on patent number EP15861189A. Click below to reveal the latest opposition data.
| Application | Filing Date | Opposition Party | Legal Status |
|---|---|---|---|
 | |||
| EP15861189A | May, 2021 | Elkington and Fife LLP | Granted and Under Opposition |
Axsome's Family Patents
Axsome drugs have patent protection in a total of 30 countries. It has a significant patent presence in the US with 60.8% of its patents being US patents. Click
below to unlock the full patent family tree.
Axsome Drug List
Given below is the complete list of Axsome's drugs and the patents protecting them.
1. Auvelity
Auvelity is protected by 120 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11844797 | Combination of dextromethorphan and bupropion for treating depression |
20 Apr, 2043
(18 years from now)
| Active |
| US11839612 | Compounds and combinations thereof for treating neurological and psychiatric conditions |
02 Mar, 2043
(18 years from now)
| Active |
| US11752144 | Compounds and combinations thereof for treating neurological and psychiatric conditions |
23 Feb, 2043
(18 years from now)
| Active |
| US12042473 | Compounds and combinations thereof for treating neurological and psychiatric conditions |
23 Feb, 2043
(18 years from now)
| Active |
| US11986444 | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan |
15 Feb, 2043
(18 years from now)
| Active |
| US12036191 | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan |
15 Feb, 2043
(18 years from now)
| Active |
| US11730706 | Treatment of depression in certain patient populations |
23 Jan, 2043
(18 years from now)
| Active |
| US11883373 | Treatment of depression in certain patient populations |
23 Jan, 2043
(18 years from now)
| Active |
| US11717518 | Bupropion dosage forms with reduced food and alcohol dosing effects |
20 Jan, 2043
(18 years from now)
| Active |
| US11925636 | Bupropion dosage forms with reduced food and alcohol dosing effects |
20 Jan, 2043
(18 years from now)
| Active |
| US11896563 | Bupropion and dextromethorphan for reduction of suicide risk in depression patients |
01 Dec, 2041
(16 years from now)
| Active |
| US10780064 | Bupropion as a modulator of drug activity |
07 Jan, 2040
(15 years from now)
| Active |
| US10925842 | Bupropion as a modulator of drug activity |
07 Jan, 2040
(15 years from now)
| Active |
| US10940124 | Bupropion as a modulator of drug activity |
07 Jan, 2040
(15 years from now)
| Active |
| US10966942 | Bupropion as a modulator of drug activity |
07 Jan, 2040
(15 years from now)
| Active |
| US10780066 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
09 Nov, 2034
(9 years from now)
| Active |
| US10058518 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10064857 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10080727 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US10092560 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US10092561 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan |
05 Nov, 2034
(9 years from now)
| Active |
| US10105327 | Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US10105361 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US10251879 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10463634 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US10512643 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US10548857 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US10596167 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan |
05 Nov, 2034
(9 years from now)
| Active |
| US10772850 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10786469 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US10786496 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US10799497 | Combination of dextromethorphan and bupropion for treating depression |
05 Nov, 2034
(9 years from now)
| Active |
| US10806710 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10864209 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10874663 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10874664 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10874665 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10881624 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US10881657 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10894046 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10894047 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10898453 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10933034 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10945973 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10966941 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US10966974 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11020389 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11058648 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11090300 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11096937 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11123343 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11129826 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11141388 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11141416 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11147808 | Method of decreasing the fluctuation index of dextromethorphan |
05 Nov, 2034
(9 years from now)
| Active |
| US11185515 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11191739 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11197839 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11207281 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11213521 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11229640 | Combination of dextromethorphan and bupropion for treating depression |
05 Nov, 2034
(9 years from now)
| Active |
| US11234946 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11253491 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11253492 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11273133 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11273134 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11285118 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11285146 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11291638 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11291665 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11298351 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11298352 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11311534 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11344544 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11357744 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11364233 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11382874 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11419867 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11426370 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11426401 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11433067 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11439636 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11478468 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11497721 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11510918 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11517542 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11517543 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11524007 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11524008 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11534414 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11541021 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11541048 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11596627 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11617728 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11617747 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11779579 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US11969421 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US12109178 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US9168234 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US9198905 | Compositions and methods for reducing dextrorphan plasma levels and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9205083 | Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan |
05 Nov, 2034
(9 years from now)
| Active |
| US9238032 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan |
05 Nov, 2034
(9 years from now)
| Active |
| US9278095 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US9314462 | Compositions and methods for increasing dextromethorphan plasma levels and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9370513 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9375429 | Compositions and methods comprising erythrohydroxybupropion and related compounds for improving the efficacy of dextromethorphan |
05 Nov, 2034
(9 years from now)
| Active |
| US9408815 | Bupropion as a modulator of drug activity |
05 Nov, 2034
(9 years from now)
| Active |
| US9421176 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9457023 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9457025 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan |
05 Nov, 2034
(9 years from now)
| Active |
| US9474731 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9486450 | Hydroxybupropion and related compounds as modulators of drug plasma levels |
05 Nov, 2034
(9 years from now)
| Active |
| US9700528 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9700553 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9707191 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9763932 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9861595 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9867819 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US9968568 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
05 Nov, 2034
(9 years from now)
| Active |
| US8569328 | Compositions and methods comprising tilidine or related compounds and dextromethorphan |
29 Oct, 2033
(8 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Auvelity's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List